Royalty Pharma PLC Stock Ownership - Who owns Royalty Pharma?

Insider buying vs selling

Have Royalty Pharma PLC insiders been buying or selling?
Pablo G. LegorretaCEO Chairman of the Board2023-05-24150,000$32.25
Rory B. RiggsDirector2023-05-221,750,000$32.82
Pablo G. LegorretaCEO Chairman of the Board2023-05-1769,612$32.94
Pablo G. LegorretaCEO Chairman of the Board2023-05-16160,388$33.57
Bonnie L. BasslerDirector2023-03-311,049$35.73
Henry A. FernandezDirector2023-03-311,049$35.73
Rory B. RiggsDirector2023-03-30130,024$36.26
Rory B. RiggsDirector2023-03-299,926$36.95
George W. LloydEVP Investments CLO2023-03-2912,779$37.03
George W. LloydEVP Investments CLO2023-03-28100,000$37.06

1 of 7

RPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPRX insiders and whales buy or sell their stock.

RPRX Shareholders

What type of owners hold Royalty Pharma PLC stock?
Morgan Stanley7.80%47,350,458$1.53BInstitution
Fmr LLC6.59%39,984,116$1.29BInstitution
Adage Capital Partners GP LLC6.38%38,714,280$1.25BInsider
Vanguard Group Inc6.25%37,930,019$1.22BInstitution
1978 Sicaf Sif Sa 1. Gg3.64%22,081,156$711.90MInsider
1978 Sicaf Sif Sa Gg3.53%21,426,170$690.78MInsider
Blackrock Inc3.27%19,848,842$639.93MInstitution
Baillie Gifford Co3.12%18,918,750$609.94MInstitution
Viking Global Investors LP1.85%11,204,249$361.22MInstitution
Jpmorgan Chase Co1.43%8,671,563$279.57MInstitution

1 of 3

RPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPRX48.10%16.18%Net SellingNet Selling
BMRN93.18%1.51%Net SellingNet Selling
ALNY81.04%18.96%Net SellingNet Selling
BGNE3.50%35.00%Net SellingNet Selling

Royalty Pharma Stock Ownership FAQ

Who owns Royalty Pharma?

Royalty Pharma (NASDAQ: RPRX) is owned by 48.10% institutional shareholders, 16.18% Royalty Pharma insiders, and 35.71% retail investors. Adage Capital Partners GP LLC is the largest individual Royalty Pharma shareholder, owning 38.71M shares representing 6.38% of the company. Adage Capital Partners GP LLC's Royalty Pharma shares are currently valued at $1.25B.

If you're new to stock investing, here's how to buy Royalty Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.